12/5/2003

Two new drugs to treat colon cancer are expected to get FDA approval next year: Erbitux is being developed by Imclone Systems and Bristol-Myers Squibb, and Genentech is developing Ivastin. Both drugs slow the growth of tumors by attacking key proteins.

Full Story:
Forbes

Related Summaries